Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. Ltd. for Oxybutynin Gel 3% in South Korea
Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. Ltd. for Oxybutynin Gel 3% in South Korea
Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. Ltd. for Oxybutynin Gel 3% in South Korea
Submitted by
moderatorj
on January 17, 2012 - 10:30pm
Source:
Yahoo/BusinessWire
News Tags:
Antares Pharma
contract
Daewoong Pharmaceuticals
Headline:
Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. Ltd. for Oxybutynin Gel 3% in South Korea
Do Not Allow Advertisers to Use My Personal information
